T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies Redazione 28 Ottobre 2021 ...
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report Redazione 28 Ottobre 2021 ...
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia Giulio D'Alfonso 28 Ottobre 2021 ...
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab Redazione 7 Ottobre 2021 ...
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma Redazione 7 Ottobre 2021 ...
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma Federica Passarelli 7 Ottobre 2021 ...
A BCMA-Targeted Bispecific Antibody Is Active in Multiple Myeloma Federica Passarelli 7 Ottobre 2021 ...
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial Redazione 23 Settembre 2021 ...
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study Redazione 23 Settembre 2021 ...